DuPont (DD) official guidance

Operating EBITDA at the midpoint is now increased to $1.760 billion, reflecting our stronger second quarter results and more than offsetting headwinds from currency.

Operating EBITDA is expected to be $900 million, resulting in Operating EBITDA margin of 24.5%, including a 50 basis point headwind from oil and gas inflation.

Therefore, for the third quarter 2026, we estimate net sales of $1.835 billion, Operating EBITDA of $448 million, and Operating EBITDA margins of 24.4%, including a 50 basis point headwind from oil and gas inflation.

Our adjusted EPS at the midpoint of $7.24 is a $0.15 increase versus our prior guidance and represents an 18% increase compared to the prior year pro forma.

Adjusted EPS at the midpoint is expected to be $3.73 per share.

Adjusted EPS is expected to be in the range of $1.80-$1.90 per share.

Given our strength in the quarter, we expect our full year free cash flow conversion to be ahead of our 90% target.

We actually see about $5 million or $6 million of incremental garment sales in the full year 2026 expectation.

Operating EBITDA margins of 24.5% includes a 30 basis point headwind from oil and gas inflation.

Operating EBITDA is expected to be $900 million, resulting in Operating EBITDA margin of 24.5%, including a 50 basis point headwind from oil and gas inflation.

Therefore, for the third quarter 2026, we estimate net sales of $1.835 billion, Operating EBITDA of $448 million, and Operating EBITDA margins of 24.4%, including a 50 basis point headwind from oil and gas inflation.

For the full year 2026, our net sales guidance now assumes organic growth to be slightly ahead of 4% on continued strength across most of our key end markets.

For the second half, at the midpoint, our estimated net sales of $3.675 billion assumes organic growth of about 6% year-over-year, driven by continued strength in Healthcare, industrial water, and aerospace end markets, as well as carry forward pricing from actions already taken.

Our third quarter net sales guidance assumes about 5% organic growth year-over-year when adjusted for the prior year timing shift and about 3% organic growth year-over-year as reported.

We'll see about 5% organic growth in Q3 and then 7% in Q4.

For the Diversified Industrials segment, we expect third quarter organic sales growth in the low-single-digits percent range on continued strength in aerospace and electric vehicle battery applications.

For the Healthcare & Water segment, we expect third quarter organic sales growth in the mid-single-digits percent range, led by strength in medical device, biopharma, and industrial water markets.

Yeah, our expectations now for the full year are more in the low to mid-single-digit range, really with the slight revision being driven just by what's going on in the Middle East, nothing structurally changing in the business in the long term.

For the second half, we do see, on average, kind of that high-single-digit growth leading to that low to mid-single-digit for the year.

Our third quarter net sales guidance assumes about 5% organic growth year-over-year when adjusted for the prior year timing shift and about 3% organic growth year-over-year as reported.